Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome-A Randomized Controlled Trial.

Front Physiol · 2018 · PMC6210452 · PMID 30410448

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

approached significancep = 0.06so close (0.05 < p ≤ 0.1)

The interaction was significant for post OGTT glucose ( p = 0.04) and approached significance for fasting insulin ( p = 0.06) when tested for mean change in burst frequency.

also in 8,237 other papers

did not reach statistical significanceno p-value reported

Total cholesterol, LDL and triglyceride levels slightly increased in the moxonidine group and decreased in the placebo group which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.